Westfield Capital Management CO LP Haemonetics Corp Transaction History

Westfield Capital Management CO LP

  • $21.6 Billion
  • Q4 2024

A detailed history of Westfield Capital Management CO LP transactions in Haemonetics Corp stock. As of the latest transaction made, Westfield Capital Management CO LP holds 805,916 shares of HAE stock, worth $54.4 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares
805,916
Previous 823,663 2.15%
Holding current value
$54.4 Million
Previous $66.2 Million 4.94%
% of portfolio
0.29%
Previous 0.31%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 11, 2025
SELL
$71.16 - $93.38 $1.26 Million - $1.66 Million
-17,747 Reduced 2.15%
805,916 $62.9 Million
Q3 2024

Nov 12, 2024
BUY
$72.45 - $91.58 $5.85 Million - $7.4 Million
80,783 Added 10.87%
823,663 $66.2 Million
Q2 2024

Aug 14, 2024
BUY
$81.24 - $97.37 $3.49 Million - $4.19 Million
43,019 Added 6.15%
742,880 $61.5 Million
Q1 2024

May 10, 2024
SELL
$71.24 - $85.35 $869,127 - $1.04 Million
-12,200 Reduced 1.71%
699,861 $59.7 Million
Q4 2023

Feb 09, 2024
BUY
$80.59 - $92.61 $12.3 Million - $14.1 Million
152,098 Added 27.16%
712,061 $60.9 Million
Q3 2023

Nov 13, 2023
BUY
$82.56 - $93.49 $12.5 Million - $14.1 Million
151,144 Added 36.97%
559,963 $50.2 Million
Q2 2023

Aug 11, 2023
BUY
$80.84 - $89.45 $2.86 Million - $3.16 Million
35,363 Added 9.47%
408,819 $34.8 Million
Q1 2023

May 12, 2023
BUY
$72.75 - $90.6 $3.63 Million - $4.52 Million
49,898 Added 15.42%
373,456 $30.9 Million
Q4 2022

Feb 13, 2023
BUY
$73.85 - $86.14 $900,083 - $1.05 Million
12,188 Added 3.91%
323,558 $25.4 Million
Q3 2022

Nov 14, 2022
SELL
$63.3 - $78.66 $488,676 - $607,255
-7,720 Reduced 2.42%
311,370 $23.1 Million
Q2 2022

Aug 12, 2022
SELL
$49.27 - $66.08 $11.5 Million - $15.4 Million
-233,221 Reduced 42.23%
319,090 $20.8 Million
Q1 2022

May 16, 2022
SELL
$43.77 - $63.22 $32.2 Million - $46.5 Million
-735,366 Reduced 57.11%
552,311 $34.9 Million
Q4 2021

Feb 10, 2022
SELL
$49.55 - $74.59 $3.42 Million - $5.14 Million
-68,937 Reduced 5.08%
1,287,677 $68.3 Million
Q3 2021

Nov 12, 2021
BUY
$57.6 - $70.59 $32.4 Million - $39.7 Million
562,628 Added 70.86%
1,356,614 $95.8 Million
Q2 2021

Aug 10, 2021
BUY
$51.81 - $118.56 $18.8 Million - $43.1 Million
363,209 Added 84.31%
793,986 $52.9 Million
Q1 2021

May 14, 2021
SELL
$111.01 - $139.48 $11.3 Million - $14.2 Million
-101,865 Reduced 19.12%
430,777 $47.8 Million
Q4 2020

Feb 12, 2021
SELL
$88.75 - $119.95 $27.5 Million - $37.2 Million
-309,769 Reduced 36.77%
532,642 $63.3 Million
Q3 2020

Nov 13, 2020
BUY
$75.65 - $93.58 $43.9 Million - $54.3 Million
579,943 Added 220.96%
842,411 $73.5 Million
Q2 2020

Aug 13, 2020
SELL
$84.96 - $118.91 $17.9 Million - $25 Million
-210,354 Reduced 44.49%
262,468 $23.5 Million
Q1 2020

May 14, 2020
SELL
$74.34 - $121.82 $9.91 Million - $16.2 Million
-133,252 Reduced 21.99%
472,822 $47.1 Million
Q4 2019

Feb 13, 2020
BUY
$114.37 - $129.46 $13.2 Million - $14.9 Million
114,991 Added 23.42%
606,074 $69.6 Million
Q3 2019

Nov 08, 2019
SELL
$117.16 - $138.52 $3.41 Million - $4.03 Million
-29,095 Reduced 5.59%
491,083 $61.9 Million
Q2 2019

Aug 13, 2019
SELL
$81.74 - $120.34 $17.1 Million - $25.1 Million
-208,801 Reduced 28.64%
520,178 $62.6 Million
Q1 2019

May 14, 2019
BUY
$83.25 - $102.12 $1.58 Million - $1.94 Million
19,027 Added 2.68%
728,979 $63.8 Million
Q4 2018

Feb 08, 2019
BUY
$90.66 - $116.63 $38 Million - $48.9 Million
419,359 Added 144.31%
709,952 $71 Million
Q3 2018

Nov 14, 2018
BUY
$89.96 - $114.58 $26.1 Million - $33.3 Million
290,593 New
290,593 $33.3 Million

Others Institutions Holding HAE

# of Institutions
348
Shares Held
55.7M
Call Options Held
600K
Put Options Held
474K
View Full List

About HAEMONETICS CORP

HAE Quotes by TradingView
  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $3.46B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track This Portfolio

Track Westfield Capital Management CO LP Portfolio

Follow Westfield Capital Management CO LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Westfield Capital Management CO LP, based on Form 13F filings with the SEC.

News

Stay updated on Westfield Capital Management CO LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email